1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Overactive Bladder Treatment Market, By Type
5.1 Introduction
5.2 Anticholinergics
5.2.1 Darifenacin
5.2.2 Fesoterodine
5.2.3 Oxybutynin
5.2.4 Solifenacin
5.2.5 Tolterodine
5.2.6 Trospium
5.2.7 Other Anticholinergics
5.3 Mirabegron
5.4 BOTOX
5.5 Neuromodulation
5.6 Other Treatments
6 Global Overactive Bladder Treatment Market, By Disease Type
6.1 Introduction
6.2 Neurogenic Overactive Bladder
6.2.1 Parkinson’s disease
6.2.2 Strokes
6.2.3 Multiple Sclerosis
6.2.4 Spinal Cord Injuries
6.3 Idiopathic Overactive Bladder
6.4 Other Disease Types
7 Global Overactive Bladder Treatment Market, By Distribution Channel
7.1 Introduction
7.2 Hospital Pharmacies
7.3 Drug Stores and Retail Pharmacies
7.4 Online Providers
7.5 Other Distribution Channels
8 Global Overactive Bladder Treatment Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Dr. Reddy’s Laboratories Ltd
10.2 Pfizer Inc.
10.3 Cipla Ltd
10.4 Lupin
10.5 Sun Pharmaceutical Industries Ltd.
10.6 Astellas Pharma Inc.
10.7 AbbVie Inc.
10.8 Alembic Pharmaceuticals Limited
10.9 Sumitomo Pharma Co., Ltd
10.10 Teva Pharmaceutical Industries Limited
10.11 Johnson & Johnson Services, Inc.
10.12 Medtronic
10.13 Sanofi
10.14 Uro Medical
10.15 Urovant Sciences
10.16 Macleods Pharmaceuticals Ltd
10.17 Endo International PLC
10.18 Hisamitsu Pharmaceutical Co., Inc.
10.19 Laborie
List of Tables
Table 1 Global Overactive Bladder Treatment Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Overactive Bladder Treatment Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Overactive Bladder Treatment Market Outlook, By Anticholinergics (2021-2030) ($MN)
Table 4 Global Overactive Bladder Treatment Market Outlook, By Darifenacin (2021-2030) ($MN)
Table 5 Global Overactive Bladder Treatment Market Outlook, By Fesoterodine (2021-2030) ($MN)
Table 6 Global Overactive Bladder Treatment Market Outlook, By Oxybutynin (2021-2030) ($MN)
Table 7 Global Overactive Bladder Treatment Market Outlook, By Solifenacin (2021-2030) ($MN)
Table 8 Global Overactive Bladder Treatment Market Outlook, By Tolterodine (2021-2030) ($MN)
Table 9 Global Overactive Bladder Treatment Market Outlook, By Trospium (2021-2030) ($MN)
Table 10 Global Overactive Bladder Treatment Market Outlook, By Other Anticholinergics (2021-2030) ($MN)
Table 11 Global Overactive Bladder Treatment Market Outlook, By Mirabegron (2021-2030) ($MN)
Table 12 Global Overactive Bladder Treatment Market Outlook, By BOTOX (2021-2030) ($MN)
Table 13 Global Overactive Bladder Treatment Market Outlook, By Neuromodulation (2021-2030) ($MN)
Table 14 Global Overactive Bladder Treatment Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 15 Global Overactive Bladder Treatment Market Outlook, By Disease Type (2021-2030) ($MN)
Table 16 Global Overactive Bladder Treatment Market Outlook, By Neurogenic Overactive Bladder (2021-2030) ($MN)
Table 17 Global Overactive Bladder Treatment Market Outlook, By Parkinson’s disease (2021-2030) ($MN)
Table 18 Global Overactive Bladder Treatment Market Outlook, By Strokes (2021-2030) ($MN)
Table 19 Global Overactive Bladder Treatment Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
Table 20 Global Overactive Bladder Treatment Market Outlook, By Spinal Cord Injuries (2021-2030) ($MN)
Table 21 Global Overactive Bladder Treatment Market Outlook, By Idiopathic Overactive Bladder (2021-2030) ($MN)
Table 22 Global Overactive Bladder Treatment Market Outlook, By Other Disease Types (2021-2030) ($MN)
Table 23 Global Overactive Bladder Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 24 Global Overactive Bladder Treatment Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
Table 25 Global Overactive Bladder Treatment Market Outlook, By Drug Stores and Retail Pharmacies (2021-2030) ($MN)
Table 26 Global Overactive Bladder Treatment Market Outlook, By Online Providers (2021-2030) ($MN)
Table 27 Global Overactive Bladder Treatment Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
